Your search returned 18 results.

Results
	1.	Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder. [electronic resource] by Kroenke, Kurt Messina, Nicholas Benattia, Isma Graepel, Jay Musgnung, Jeff Producer: 20060328 In: The Journal of clinical psychiatry vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo. [electronic resource] by Clayton, Anita H Reddy, Sujana Focht, Kristen Musgnung, Jeff Fayyad, Rana Producer: 20130919 In: The journal of sexual medicine vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Patient outcomes with education, drug therapy, and support: a study of venlafaxine ER-treated outpatients with major depressive disorder. [electronic resource] by Lobello, Kasia Reddy, Sujana Musgnung, Jeff Pedersen, Ronald Ninan, Philip T Producer: 20120302 In: Psychopharmacology bulletin vol. 43 Availability: No items available. Save to lists Add to cart (remove)
	4.	Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study. [electronic resource] by Thase, Michael E Ninan, Philip T Musgnung, Jeff J Trivedi, Madhukar H Producer: 20121002 In: The primary care companion for CNS disorders vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d. [electronic resource] by Khan, Arif Musgnung, Jeff Ramey, Tanya Messig, Michael Buckley, Gina Ninan, Philip T Producer: 20150209 In: Journal of clinical psychopharmacology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studies. [electronic resource] by Papakostas, George I Culpepper, Larry Fayyad, Rana S Musgnung, Jeff Guico-Pabia, Christine J Producer: 20140508 In: International clinical psychopharmacology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. [electronic resource] by Kornstein, Susan G Jiang, Qin Reddy, Sujana Musgnung, Jeff J Guico-Pabia, Christine J Producer: 20100909 In: The Journal of clinical psychiatry vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. [electronic resource] by Davidson, Jonathan Rothbaum, Barbara O Tucker, Phebe Asnis, Gregory Benattia, Isma Musgnung, Jeff J Producer: 20060810 In: Journal of clinical psychopharmacology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician. [electronic resource] by Reddy, Sujana Kane, Cecelia Pitrosky, Bruno Musgnung, Jeff Ninan, Philip T Guico-Pabia, Christine J Producer: 20100305 In: Current medical research and opinion vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder. [electronic resource] by Ninan, Philip T Musgnung, Jeff Messig, Michael Buckley, Gina Guico-Pabia, Christine J Ramey, Tanya S Producer: 20150703 In: The primary care companion for CNS disorders vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. [electronic resource] by Davidson, Jonathan Baldwin, David Stein, Dan J Kuper, Enrique Benattia, Isma Ahmed, Saeed Pedersen, Ron Musgnung, Jeff Producer: 20061106 In: Archives of general psychiatry vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis. [electronic resource] by Stein, Dan J Pedersen, Ron Rothbaum, Barbara O Baldwin, David S Ahmed, Saeeduddin Musgnung, Jeff Davidson, Jonathan Producer: 20090313 In: The international journal of neuropsychopharmacology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale. [electronic resource] by Davidson, Jonathan Baldwin, David S Stein, Dan J Pedersen, Ron Ahmed, Saeed Musgnung, Jeff Benattia, Isma Rothbaum, Barbara O Producer: 20081023 In: International clinical psychopharmacology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	A meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sites. [electronic resource] by Dunlop, Boadie W Thase, Michael E Wun, Chuan-Chuan Fayyad, Rana Guico-Pabia, Christine J Musgnung, Jeff Ninan, Philip T Producer: 20130826 In: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder. [electronic resource] by Clayton, Anita H Kornstein, Susan G Dunlop, Boadie W Focht, Kristen Musgnung, Jeff Ramey, Tanya Bao, Weihang Ninan, Philip T Producer: 20140407 In: The Journal of clinical psychiatry vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo. [electronic resource] by Rothbaum, Barbara O Davidson, Jonathan R T Stein, Dan J Pedersen, Ron Musgnung, Jeff Tian, Xiao Wei Ahmed, Saeeduddin Baldwin, David S Producer: 20090305 In: The Journal of clinical psychiatry vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. [electronic resource] by Kocsis, James H Thase, Michael E Trivedi, Madhukar H Shelton, Richard C Kornstein, Susan G Nemeroff, Charles B Friedman, Edward S Gelenberg, Alan J Dunner, David L Hirschfeld, Robert M A Rothschild, Anthony J Ferguson, James M Schatzberg, Alan F Zajecka, John M Pedersen, Ronald D Yan, Bing Ahmed, Saeed Musgnung, Jeff Ninan, Philip T Keller, Martin B Producer: 20070928 In: The Journal of clinical psychiatry vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. [electronic resource] by Keller, Martin B Trivedi, Madhukar H Thase, Michael E Shelton, Richard C Kornstein, Susan G Nemeroff, Charles B Friedman, Edward S Gelenberg, Alan J Kocsis, James H Dunner, David L Hirschfeld, Robert M A Rothschild, Anthony J Ferguson, James M Schatzberg, Alan F Zajecka, John M Pedersen, Ronald D Yan, Bing Ahmed, Saeeduddin Musgnung, Jeff Ninan, Philip T Producer: 20070924 In: The Journal of clinical psychiatry vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)